CliffBio
small molecule

EDURANT

RILPIVIRINE HYDROCHLORIDE

Loss of exclusivitySeptember 2027FDA regulatory exclusivity expiry
CompanyJANSSEN PRODUCTS LP

Drug detail

Brand nameEDURANT
Active ingredientRILPIVIRINE HYDROCHLORIDE
StrengthEQ 25MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2011
Marketing statusRX

Regulatory exclusivity

CodeExpires
PEDSeptember 2027
NPPMarch 2027

More from JANSSEN PRODUCTS LP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

EDURANT patent cliff — loss of exclusivity September 2027 | CliffBio